ISSN 1662-4009 (online)

ey0018.2-4 | Neonatal hypoglycaemia | ESPEYB18

2.4. Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose in Well Babies (GLOW) Study.

DL Harris , PJ Weston , GD Gamble , JE Harding

J Pediatr. 2020 Aug;223:34–41.e4. doi: 10.1016/j.jpeds.2020.02.079. PMID: 32381469.In this study, the plasma and interstitial (GCMS) glucose levels were measured in term healthy newborns for a period of 5 days to understand the changes in the glucose levels after birth. The findings suggest that in normal term healthy newborns if hypoglycaemia persists after the 4th day of life, t...

ey0017.2-5 | Neonatal Hypoglycaemia | ESPEYB17

2.5. Glucose profiles in healthy term infants in the first 5 days: the glucose in well babies (GLOW) study

DJ Harris , PJ Weston , GD Gamble , JE Harding

To read the full abstract: J Pediatr. 2020 May 4. pii: S0022-3476(20)30295-X. doi: 10.1016/j.jpeds.2020.02.079. [Epub ahead of print]. PMID:32381469Understanding the typical patterns of blood glucose profiles in healthy term infants is needed to inform guidelines for the management of hypoglycaemia. Typically blood glucose levels fall rapidly after birth (30–90 min), then stabiliz...

ey0015.2-7 | Dextrose gel and breast feeding should be considered first-line oral treatment of infants with hypoglycemia | ESPEYB15

Dextrose gel and breast feeding should be considered first-line oral treatment of infants with hypoglycemia

DL Harris , GD Gamble , PJ Weston , JE Harding

To read the full abstract: J Pediatr. 2017 Nov;190:136-141Neonatal hypoglycaemia is common, affecting around 15% of at risk newborns such as preterm, IUGR and infants of diabetic mothers. Delay and inappropriate treatment of hypoglycemia can lead to irreversible brain damage. It is frequently managed by providing infants with an alternative source of glucose, given enterally with infant for...